Role of miR‐223‐3p in pulmonary arterial hypertension <i>via</i> targeting <i>ITGB3</i> in the ECM pathway

Abstract

MiR-223-3p alleviated the progression of PAH by suppressing the expression of ITGB3, a finding which provides novel targets for clinical treatment.